Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study

Title
Impact of fingolimod on clinical and magnetic resonance imaging outcomes in routine clinical practice: A retrospective analysis of the multiple sclerosis, clinical and MRI outcomes in the USA (MS-MRIUS) study
Authors
Keywords
Fingolimod, Real-world evidence, Relapsing multiple sclerosis, MRI outcomes, Brain atrophy, Clinical outcomes
Journal
Multiple Sclerosis and Related Disorders
Volume 27, Issue -, Pages 65-73
Publisher
Elsevier BV
Online
2018-10-04
DOI
10.1016/j.msard.2018.09.037

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started